Chlorambucil and prednisolone, two commonly used drugs in the treatment of chronic lymphocytic leukemia (CLL), induce apoptosis in CLL cells. We have investigated the involvement in this apoptotic cell death of caspases, which cleave critical cellular substrates thereby acting as the executioners of the apoptotic process. Induction of spontaneous or chlorambucil/ prednisolone-induced apoptosis of freshly isolated B-CLL cells in culture resulted in the activation of the 'effector' caspases, -3 and -7, but generally not of caspase-2. Activation of caspases-3 and -7 was accompanied by the proteolysis of the DNA repair enzyme, poly (ADP-ribose) polymerase. Induction of apoptosis was also accompanied by the processing of caspase-8, the extent of which varied between patients. Induction of apoptosis and processing of all the caspases was inhibited by the cell permeable caspase inhibitor, benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethyl ketone (Z-VAD.fmk). Our results demonstrate a key role for the activation and processing of caspases in the execution phase of apoptosis in CLL cells. Apoptosis of CLL cells resulted in the selective activation of some but not all caspases. Our results suggest that the dysregulation of apoptosis observed in CLL may be due to the signalling leading to the activation of caspases rather than a deletion of pro-caspases. High levels of caspase-8 in CLL cells in conjunction with low levels of CD95 receptor may offer new therapeutic opportunities for the treatment of CLL.
Introduction
B cell chronic lymphocytic leukemia (B-CLL) is the most common leukemia in the western World. It is characterised by the accumulation of neoplastic, quiescent, immunologically incompetent CD5 + B lymphocytes in the peripheral blood of CLL patients, which arise from an uncharacterised defect(s) in apoptosis. 1, 2 Apoptosis is a well characterised mode of cell death that occurs throughout normal growth and development. Disturbances in apopotosis have been reported in cancer, AIDS and neurodegenerative disorders. 3 Apoptosis can be divided into two phases: an initial condemned phase where cells are committed to die, without any morphological changes followed by an execution phase when all the characteristic biochemical and morphological changes of apoptosis occur. 4 Multiple factors function in a highly complex controlled process leading to cell death by apoptosis. Recent research in CLL has focused on the ratio of the anti-apoptotic Bcl-2 to the pro-apoptotic Bax, which only partially explains the sensitivity of CLL cells to apoptosis induced by certain chemotherapeutic agents. 5, 6 Many cancer chemotherapeutic agents induce apoptosis in susceptible cells. 7 The recognition that a family of at least 10 aspartate-specific cysteine proteases called caspases act as the executioners of apoptotic death, 8, 9 suggests that they may also play a critical role in chemosensitivity. The caspases are synthesized as inactive pro-enzymes, comprising an N-terminal prodomain of varying length together with one large and one small subunit. Caspases are activated, following cleavage after aspartate residues, and then cleave important cellular proteins, such as the DNA repair enzyme poly (ADP-ribose) polymerase (PARP), and the nuclear lamins, so resulting in the dramatic biochemical and morphological changes characteristic of apoptosis. 8, 9 Caspases may be divided into 'activator' caspases with long prodomains (caspases-8, -9 and -10), which activate the 'effector' caspases with short prodomains (caspases-3, -6 and -7), which in turn cleave intracellular substrates. 10 Caspase-3 and caspase-7 are two of the major effector caspases involved in the execution phase of apoptosis and are responsible for the cleavage of many critical cellular substrates including PARP, fodrin and retinoblastoma protein. 8, 9 Caspase-8 (MACH/FLICE/Mch5) has been implicated as one of the main 'activator' caspases in receptor-mediated apoptosis, such as CD95 (Fas or APO-1)-or tumor necrosis factor-induced apoptosis. 11, 12 Triggering of cell membrane receptors by anti-CD95 agonistic antibodies, results in the recruitment of the adaptor molecule FADD/MORT1 to a death inducing signalling complex (DISC). 13, 14 FADD possesses both a death domain and a death effector domain, the latter binding to one of two death effector domains at the N-terminus of caspase-8. 11, 12 This results in the recruitment and subsequent activation of caspase-8 by an as yet unknown mechanism. 15 In addition, in vitro caspase-8 can activate all other caspases. 16 Based on these observations, caspase-8 has been proposed to be the most apical caspase of a hypothetical caspase cascade. Thus death domain containing molecules, such as FADD, serve to couple death receptors to caspases, the apoptotic executioners. 11, 12 The importance of caspase activation in spontaneous and chemotherapy-induced apoptosis in leukaemic cells from patients with CLL is not known. Recently it has been shown that peripheral blood mononuclear cells from CLL patients are caspase-3 immunopositive 17 and that glucocorticoid-induced apoptosis of CLL lymphocytes requires protease activation and is accompanied by cleavage of PARP and lamin B 1 together with the loss of caspase-3. 18, 19 Multiple species of caspases-3 and -6 appear to be the major pool of activated caspases in various tumor cell lines induced to undergo apoptosis. 20 In addition to caspases-3 and -6, caspases-2 and -7 are also activated in human monocytic tumor cells induced to undergo apoptosis by various stimuli. 21 The cellular and tissue distribution of different caspases and their substrate specificity is generally not known, although this is clearly important as exemplified by the inability of some neuronal but not other cells to undergo apoptosis in caspase-3 null mice. 22 In this study, we have investigated the activation/processing of caspases in B-CLL cells exposed to chlorambucil and prednisolone, two drugs commonly used in the treatment of D King et al 1554 CLL. Caspases-3, -7 and -8 but not caspase-2, are activated in spontaneous and drug-induced apoptosis of B-CLL cells. Inhibition of the processing of the caspases results in inhibition of apoptosis demonstrating a key role(s) for the caspases in the induction of apoptosis in CLL cells.
Materials and methods

Patients, isolation of B-CLL cells and culture
Peripheral blood samples were obtained from unselected B-CLL patients staged according to the Binet system, after informed consent and with local ethical committee approval. Whole blood was collected into K + /EDTA tubes, and layered over Ficoll (Ficoll-Paque; Pharmacia Biotech, Uppsala, Sweden). Following centrifugation for 20 min at 400 g, mononuclear cells were aspirated off, and washed in two changes of RPMI 1640 medium (GibcoBRL, Paisley, UK) supplemented with 10% FCS (Sigma, Poole, UK). Freshly isolated lymphocytes were suspended in culture medium (as above) at an average density of 2 × 10 6 cells/ml. Benzyloxycarbonyl-ValAla-Asp (OMe) fluoromethyl ketone (Z-VAD.fmk), a cell permeable caspase inhibitor, was obtained from Enzyme Systems Products, Dublin, CA, USA. A proportion of the isolated cells was incubated in six-well plates at 37°C in an atmosphere containing 5% CO 2 . Samples of the cells were incubated in the presence or absence of chlorambucil (3-15 m) or prednisolone (20-200 m) (Sigma), which partly reflected the therapeutic levels in patients receiving these drugs. Duplicate samples of untreated and drug-treated cells were pre-incubated for 30 min with Z-VAD.fmk (100 m). At specified times, samples were either analysed for apoptosis using Annexin V labelling or stored at −80°C for subsequent analysis of caspase expression.
Annexin V binding
Apoptotic cells, with externalised phosphatidylserine, were quantified by flow cytometry after Annexin V-FITC and propidium iodide labelling. 23 Briefly, 1 × 10 6 cells were micro-centrifuged at 6000 r.p.m. and then re-suspended in 1 ml Annexin V buffer (10 mm Hepes/NaOH pH 7.4, 150 mm NaCl, 5 mm KCl, 1 mm MgCl 2 , 1.8 mm CaCl 2 ). Annexin V-FITC (Bender MedSystems, Vienna, Austria) was added to a final concentration of 2 g/ml. After incubation at room temperature for 8 min, propidium iodide (Sigma) was added (50 l of 50 g/ml stock in PBS), and the cells incubated for a further 2 min before being placed on ice prior to flow cytometric analysis on a Becton Dickinson FACStar Plus (San Jose, CA, USA), using Lysis II software. Apoptotic cells were quantified as Annexin V + /propidium iodide − cells.
Immunoblotting
Frozen cell samples were lysed in a 10% SDS sample loading buffer containing bromophenol blue. Samples were run on SDS-polyacrylamide gels before being blotted overnight onto nitrocellulose membranes (Hybond C-extra; Amersham, Bucks, UK). 24 Membranes were blocked for 60 min in 5% non-fat dried milk in Tris-buffered saline containing 0.1% Tween 20. The membranes were incubated with the primary antibody for 1 h at room temperature followed by washing with Tris-buffered saline containing 1% Tween-20 and then incubated with horseradish-peroxidase-conjugated secondary antibody (rabbit anti-mouse IgG or goat anti-rabbit IgG; Dako, High Wycombe, Bucks, UK) for a further hour. Rabbit polyclonal antibodies directed to the p17 large subunit of caspase-3 (kindly provided by Dr D Nicholson, Merck-Frosst, Quebec, Canada), which recognize the proform of caspase-3 and its p17-20 large subunit(s), and to the carboxy terminus of caspase-2, which recognize both pro-caspase-2 and the p12 subunit, were used (Santa Cruz Biotechnology, Santa Cruz, CA, USA). A mouse monoclonal antibody to poly (ADP-ribose) polymerase (PARP), which recognizes both intact PARP (116 kDa) and a cleavage product of 89 kDa (kindly provided by Dr G Poirier, Laval University, Quebec, Canada) and to caspase-7, which recognizes the pro-caspase-7 and the catalytically active p19 large subunit were used as described. 21 A rabbit polyclonal antibody to caspase-8 was raised against the large subunit of caspase-8 (amino acids 210-374) and kindly supplied by Dr X-M Sun (MRC Toxicology Unit, University of Leicester, Leicester, UK). The antibody obtained was characterized by ELISA and Western blot analysis, which verified that it recognized intact procaspase-8 and the p43 and p18 subunits. The blots were developed using enhanced chemiluminescence (ECL; Amersham) according to the manufacturer's instructions. Blots were exposed to X-OMAT LS film (Kodak, Rochester, NY, USA) for appropriate time intervals in order to visualise caspase activation/substrate cleavage.
Results
Inhibition of spontaneous apoptosis in CLL cells by Z-VAD.fmk
Apoptosis was assessed in CLL cells using Annexin V to measure externalisation of phosphatidylserine ( Figure 1 ). Freshly isolated cells, prior to culture, showed a very low level of spontaneous apoptosis, as measured by Annexin V (Figure 1a ). During culture, the cells underwent spontaneous apoptosis (Figure 1b) , which was increased in the presence of chemotherapeutic agents, such as chlorambucil ( Figure 1c) . A variable amount of spontaneous apoptosis was observed (Tables  1 and 2) in agreement with other studies. 25 The measurement of phosphatidylserine exposure allowed a clear quantification of the percentage of apoptotic cells. We have previously shown that in CLL cells this is a more sensitive and quantitative measure of apoptosis than DNA fragmentation (data not shown). In order to assess the role of caspases in the execution phase of apoptosis in B-CLL cells, we used Z-VAD.fmk, a cell permeable caspase inhibitor, which inhibits apoptosis in many different model systems. 21 ,26,27 Z-VAD.fmk (100 m) inhibited spontaneous apoptosis in all but one of the patient samples examined (Table 1) supporting the involvement of caspases in the spontaneous apoptosis of CLL cells. In order to obtain more definitive evidence for the involvement of caspases, we examined the processing/activation of the effector caspases as well as the proteolysis of PARP, which has been used as a marker of apoptosis. 28 
Activation of caspase-3 and caspase-7 in apoptosis of CLL cells
We have examined the time course of induction of apoptosis in four previously untreated Binet stage A cases of CLL. In Freshly isolated CLL cells from patients were cultured for 20 h at 37°C either alone or in the presence of Z-VAD.fmk (100 M) as indicated. Apoptosis was assessed by measuring externalisation of phosphatidylserine using Annexin V staining as described in Materials and methods.
each patient, a time-dependent induction of spontaneous apoptosis was observed (Figure 2a) . Cells from these patients exposed to chlorambucil, showed a concentration-dependent increase in the induction of apoptosis compared to control cells (Figure 2a ). These cells were also analysed by immunoblotting for activation of caspases -3 and -7. Freshly isolated untreated CLL cells contained primarily the proform of caspase-3 ( Figure 2b , lane 1). Processing of caspase-3 at Asp 175 between the large and small subunits yields a p20 subunit, which is further processed at Asp 9 and Asp 28 to yield p19 and p17 large subunits. 29 A time-dependent processing of caspase-3 to its catalytically active large subunit(s), p17-p20, was observed ( Figure 2b, lanes 2-5) , which was increased in the presence of chlorambucil (Figure 2b, lanes 6-9) . We have seen activation of caspase-3 in both spontaneous and druginduced apoptosis in all nine samples examined to date (Table 2) .
Caspase-7 was also present in freshly isolated CLL cells as a ෂ35 kDa proform without any detectable large p19 subunit (Figure 2c, lane 1) . Processing of caspase-7 initially occurs at Asp 198 between the large and small subunits, followed by cleavage at Asp 23 to yield the p19 large subunit. 21 A timedependent processing of caspase-7 to its p19 subunit was observed in spontaneous apoptosis, which was also increased as a result of exposure to chlorambucil (Figure 2c ). Caspase-7 was activated in all 10 samples of spontaneous and druginduced apoptosis examined (Table 2) . Thus, induction of apoptosis in CLL cells was accompanied by the processing of both the effector caspases-3 and -7 to their catalytically active large subunits.
Caspase-2 processing does not generally accompany apoptosis of CLL cells
Several recent studies have shown that caspase-2 (ICH-1, Nedd2) is processed in some but not all cells during the induction of apoptosis. 21, 30, 31 The prodomain of caspase-2 binds to the adaptor molecule RAIDD/CRADD which also binds the receptor-interacting protein RIP and may thus regulate apoptosis. 32, 33 It is not known which if any intracellular substrates are cleaved by caspase-2 in apoptosis.
In order to investigate the possible importance of caspase-2 in apoptosis of CLL cells, we used an antibody which recognizes both the proform and the small p12 subunit of caspase-2. In agreement with previous studies, 21 induction of apoptosis in the human monocytic tumor cell line, THP.1, resulted in the activation of caspase-2 to its ෂp12 small subunit ( Figure 3, lane 1) and was included as a positive control for the processing of caspase-2. In cells undergoing spontaneous and drug-induced apoptosis, processing of procaspase-2 was seen in only 1/9 samples examples to date ( Table  2 ). The results from this case are shown in more detail ( Figure  3 ). Untreated freshly isolated CLL cells from this patient contained primarily the ෂp48 proform of caspase-2 with no detectable small p12 subunit ( Figure 3, lane 2) . These freshly isolated cells also contained an immunologically reactive protein of ෂ33 kDa, which may represent an early processed form of caspase-2 ( Figure 3, lane 2) . In cells undergoing spontaneous apoptosis, little or no cleavage of procaspase-2 to its p12 small subunit was observed (Figure 3, lane 3) . Induction of apoptosis with prednisolone resulted in the processing of procaspase-2 to its p12 subunit (Figure 3, lane 4) , which was more marked with chlorambucil ( Figure 3, lane 5) . Thus, although processing of caspase-2 was observed in cells from this patient, it did not appear to be a general feature Peripheral blood lymphocytes from patients diagnosed with B-CLL were cultured in vitro for 20 h either alone or in the presence of prednisolone (Pd) and chlorambucil (Chl). Both spontaneous (spon) and drug-induced apoptosis were then determined by Annexin V binding. Activation of caspases -2, -3, -7 and -8 as well as proteolysis of PARP was determined by Western blot analysis. Expression of the proforms of the caspases was found in all cases examined. A '+' indicates processing of the proenzyme to cleaved products or an active subunit was observed following in vitro culture with and without addition of the drugs, whereas a '−' indicates no such activation was observed. ND indicates not determined. Cp indicates previous treatment of the patient with cyclophosphamide.
accompanying either spontaneous or drug-induced apoptosis of CLL cells.
Activation of the effector caspases result in the cleavage of PARP
As processing of caspases-3 and -7 was observed, we also examined CLL cells for the cleavage of PARP, a substrate for both these caspases.
34,35
Induction of apoptosis was accompanied by a time-dependent cleavage of PARP to a characteristic 89 kDa signature fragment (Figure 4 ). This proteolytic product arises following cleavage of PARP at a DEVD↓G sequence by caspase-3 and caspase-7. [34] [35] [36] The induction of apoptosis and the cleavage of PARP were both induced following exposure of the CLL cells to chlorambucil, which was most marked at 20 h (Figure 4 ). This cleavage of PARP was inhibited by Z-VAD.fmk (data not shown) further supporting the involvement of caspases in the execution phase of apoptosis in CLL cells.
Activation of caspase-8 during apoptosis of CLL cells
Although caspase-8 has been implicated as one of the main 'activator' caspases in receptor-mediated apoptosis, 11, 12 its role if any, in drug-induced apoptosis is not clear. In order to examine its possible involvement in apoptosis of CLL cells, we utilised a caspase-8 antibody. In freshly isolated CLL cells, the antibody recognised two protein(s) of ෂ55 kDa ( Figure 5 ). Lower exposure of the blots clearly showed that in 7/7 patients examined to date, there were two immunoreactive proteins of ෂ55 kDa (data not shown), most probably corresponding to two different isoforms of caspase-8, MACH␣1 and MACH␣2. 11, 37 In addition, the freshly isolated cells also contained two immunoreactive proteins of ෂ43 kDa (Figure 5a and b, lane 1), which probably resulted from loss of the small p12 subunit following cleavage at Asp 374. 15 The cells also contained two immunoreactive proteins of ෂ28 kDa, which may have arisen following removal of the two death effector domains following cleavage at Asp 216. As yet we have not observed a clear time-dependent or drug-induced formation of the ෂ28 kDa fragments. Culture of the CLL cells resulted in a time-dependent processing of the ෂ55 kDa protein(s) to fragments of ෂ43 and a small amount of an 18 kDa fragment ( Figure 5a, lanes 2-5) . Formation of the 18 kDa large subunit most probably occurs following further cleavage of the ෂp43 fragments at Asp 216. Formation of all these fragments was possibly only slightly increased following treatment of CLL cells with chlorambucil ( Figure 5a, lanes 6-9) . The time course of cleavage of caspase-8 appeared similar to that of caspase-3 and caspase -7. Although processing of caspase-8 was observed in all seven samples analyzed to date only small amounts of caspase-8 was processed (Table 2 ). Some interindividual variation was also observed, for example in patient 28, only a small amount of caspase-8 was activated to fragments of ෂp43 with little or no other products being formed (Figure 5b) . Thus, interindividual variation was observed in the activation of caspase-8, the relevance of which is under further investigation. Particularly striking in all samples was the apparently high levels of the proform of caspase-8 and the relatively small amounts of this proform which were processed during culture (Figure 5a and b) .
Z-VAD.fmk inhibits the processing of caspases in CLL cells
In order to determine at what stage of the apoptotic process, Z-VAD.fmk was inhibiting apoptosis (Table 1) , we examined its ability to inhibit the processing of different caspases. Freshly isolated CLL cells from patient 14 contained primarily the proform of caspase-3 ( Figure 6 , lane 2). Spontaneous apoptosis was accompanied by the processing of caspase-3 to its catalytically active large subunit(s) (Figure 6, lane 3) , which was increased following treatment with both prednisolone and chlorambucil ( Figure 6, lanes 4 and 5, respectively) , commensurate with their ability to induce apoptosis. In both spon- taneous and drug-induced apoptosis, Z-VAD.fmk almost completely inhibited the processing of procaspase-3 to its catalytically active large subunits ( Figure 6, lanes 6-8) . Similarly in this patient, these treatments induced the processing of caspase-7 to its p19 large subunit, which was also inhibited by Z-VAD.fmk (data not shown). Z-VAD.fmk also inhibited the drug-induced processing of caspase-2 observed in patient 14 ( Figure 3, lanes 7 and 8) . In patient 28, Z-VAD.fmk inhibited the activation/processing of caspase-8 to a p43 fragment (Figure 5b, lanes 5-7) . Thus, Z-VAD.fmk acts to block drug-induced apoptosis of CLL cells by blocking the activation/processing of all four caspases examined.
Discussion
In this study we have demonstrated that induction of apoptosis of CLL cells leads to the selective induction of some but not all caspases. We have shown the processing/activation of at least three caspases (caspases-3, -7 and -8) during the execution phase of apoptosis of CLL lymphocytes whereas caspase-2 does not generally appear to be activated. Recent studies have implicated a role for the release of mitochondrial cytochrome c in the activation of procaspase-3 provided Apaf-3, now identified as caspase-9, and dATP are present. 38, 39 In all the patients examined, activation of the effector caspases, -3 and -7, were observed (Table 2 and Figures 2 and 6 ) suggesting that these caspases may be responsible for the cleavage of PARP found in CLL cells in this and other studies. 18, 19 Further support for this hypothesis was provided by the observations that Z-VAD.fmk, a cell permeable caspase inhibitor, inhibited the activation/processing of all the caspases studied, as well as the cleavage of PARP and both spontaneous and drug-induced apoptosis of CLL cells (Table 1 and Figures 2,  3, 5 and 6 ). Thus these effector caspases also play a central role in the execution phase of apoptosis in CLL cells as they do in other cell systems. 8, 9 In 8/9 patients, caspase-2 was not activated (Table 2 ). In only one case was activation observed (Figure 3) . At the time of sampling this patient was Binet stage A, but in the last year has progressed to stage C. Activation of caspase-2 during the execution phase of apoptosis has been observed in different tumor cell lines. 21, 30, 31 The precise mechanism by which procaspase-2 is activated in cells is not known. It may involve recruitment through an adapter such as RAIDD/CRADD, 32, 33 or based on activities of recombinant enzymes, it has been proposed that caspase-3 activates pro-caspase-2. 30, 40 In our studies no activation of procaspase-2 was observed even in the presence of activated caspase-3 and caspase-7 (Table 2) demonstrating that neither caspase-3 nor -7 activates procaspase-2 in CLL cells. Our data also demonstrate that activation of caspase-2 is not required for the induction of apoptosis in CLL cells.
Our results on the activation/processing of caspase 8 are particularly intriguing. Triggering of the CD95 receptor leads to the recruitment and activation of caspase-8, which may then act as the apical 'initiator' caspase responsible for the activation of other caspases and the execution of apoptosis. 11, 12 Whilst caspase-8 is activated early in CD95-induced apoptosis, little is known about its role, if any, in drug-induced apoptosis. Of particular interest in the present studies were the high levels of procaspase-8 present in 7/7 patients examined to date (Table 2 ). Procaspase-8 was present as two main forms of ෂ55 and 53 kDa, which correspond to caspase-8/a (MACH␣1) and caspase-8/b (MACH␣2). 37 At the end of the culture, despite the induction of significant apoptosis (25-65%), most of the caspase-8 was still present as the proform with only small amounts being processed ( Figure 5 ), in contrast to CD95-induced apoptosis when all the caspase-8 is rapidly processed. 37 In addition in 2/4 cases, caspase-8 was activated concurrently with caspases -3 and -7 after 6 to 10 h of in vitro culture. Our results would seem to preclude an initiator role for caspase-8 in drug-induced apoptosis of CLL cells, and suggest that it may be activated non-specifically by other caspases.
Some cytotoxic agents, such as doxorubucin, induce apoptosis in human leukemic cell lines and neuroblastoma cells via the CD95 receptor/ligand system, a hypothesis supported by the finding that these cells also display cross-resistance between the cytotoxic agent and CD95-induced apoptosis. [41] [42] [43] However, other studies have suggested that chemotherapy-induced apoptosis is not dependent on CD95/CD95 ligand interactions. 44, 45 While the reasons for these discrepancies are not clear, they may be related to the rate of induction of apoptosis. For example, in those systems where a positive relationship between chemotherapy and the involvement of CD95 receptor/ligand system has been implicated, [41] [42] [43] apoptosis is induced over a long period of time (24-48 h) so allowing the synthesis of new proteins. The possible involvement of the CD95 receptor/ligand system in chemotherapy-induced apoptosis in CLL cells remains to be determined. Interestingly CLL cells have been reported to have undetectable or very low levels of CD95 expression. [46] [47] [48] This expression can be increased following in vitro activation with interleukin-2, Staphlyococcus aureus 1 or CD40 although in some cases this may lead to proliferation. 46, 48 Thus, CLL cells express high levels of caspase-8 in conjunction with very low levels of CD95 receptor. These results highlight the possibility of developing new therapies for CLL based on the upregulation of CD95 or other death receptors, which would synergize with the high levels of caspase-8 in CLL cells. Freshly isolated B-CLL cells possess caspase-2, -3, -7 and -8. Some of these caspases can be activated to cleave protein substrates such as PARP. Our results have also demonstrated that B-CLL cells possess the complete apoptotic machinery required to execute the apoptotic program. Thus the dysregulation of apoptosis in CLL cells leading to an abnormal accumulation of CD5
+ lymphocytes does not appear to be due either to a deletion of pro-caspases or to point mutations leading to their inactivation. Rather, our studies suggest that the molecular basis of dysregulated apoptosis in vivo may reside in the signalling leading to the activation of caspases.
